Saskatchewan Epilepsy Program, Department of Medicine, University of Saskatchewan Saskatoon, SK, Canada
Neurology Section, Hospital Pablo Tobón Uribe, Medellín, Colombia
Saskatchewan Epilepsy Program, Department of Surgery, University of Saskatchewan Saskatoon, SK, Canada
Correspondence: José F. Téllez-Zenteno
Department of Medicine,
Division of Neurology Royal University Hospital,
Saskatoon, SK, S7N 0W8 Canada
Temporal lobe epilepsy (TLE) is the most common type of drug-resistant epilepsy in adults and commonly requires surgical treatment. While an overwhelming preponderance of literature supports the notion that a large percentage of patients with TLE benefit from surgery, there is a paucity of outcome data on patients who demonstrate a sustained response to pharmacological treatment. In this study, we present an adult cohort of patients with TLE, with the purpose of identifying the proportion of patients with a mild course of the disease, as well as potential risk factors.